Related Experiment Video
Updated: Jul 27, 2026
Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Anti-oxidant therapy for the treatment of coronary artery disease
1Clinical Investigation Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, UK. m.j.kendall@bham.ac.uk
Insights
Antioxidants may reduce coronary artery disease mortality by preventing low-density lipoprotein cholesterol (LDL-C) oxidation. Further research is needed to establish the role of antioxidant therapy in a comprehensive prevention strategy.
Area of Science:
- Cardiovascular Medicine
- Oxidative Stress Research
Background:
- Coronary artery disease (CAD) is a leading cause of death globally, often presenting as myocardial infarction or heart failure.
- Preventive strategies are crucial due to high incidence, mortality, and out-of-hospital deaths.
- Oxidation of low-density lipoprotein cholesterol (LDL-C) is a key factor in atheroma development.
Purpose of the Study:
- To review the role of antioxidants in coronary artery disease (CAD) prevention.
- To emphasize the need for an integrated approach combining pharmacological and non-pharmacological measures.
- To advocate for a structured, scientific approach to antioxidant therapy.
Main Methods:
- Review of existing literature on CAD, oxidative stress, and antioxidant interventions.
- Discussion of pharmacological and non-pharmacological preventive measures.
- Outline of requirements for effective antioxidant therapy and clinical trials.
Main Results:
- Antioxidant intervention targeting LDL-C oxidation shows potential for reducing CAD mortality.
- Current evidence necessitates a broader strategy for CAD prevention.
- A structured approach to antioxidant therapy requires demonstrating oxidative stress and its correction.
Conclusions:
- Antioxidant therapy may be a valuable component of CAD prevention if applied scientifically.
- Further clinical trials are needed to define the precise role of antioxidants in managing CAD.
- A comprehensive strategy including lifestyle modifications and pharmacological treatments is essential for CAD prevention.
Abstract:
Coronary artery disease is the most common cause of death in developed countries. It may present in many different ways, but most frequently as a myocardial infarction, sudden death, angina or heart failure. Preventive measures in relation to coronary artery disease are particularly important because of its high incidence, high mortality and because most patients die outside hospital. Since the oxidation of low density lipoprotein cholesterol (LDL-C) is a critical early step in the process of atheroma formation, taking anti-oxidants to prevent LDL-C oxidation may prove a very effective means of reducing coronary artery disease mortality. However, the role of anti-oxidants in coronary artery disease prevention needs to be evaluated as part of an overall strategy that includes pharmacological and non-pharmacological measures, which are described in this review. In addition, a more structured and scientific approach to anti-oxidant therapy needs to be adopted. This requires that evidence for oxidative stress in a particular condition is obtained, the nature and severity determined and an appropriate anti-oxidant is administered, in an effective dose, which can be shown to correct the oxidative stress. When this is achieved, meaningful clinical trials should be possible, which will determine the place of anti-oxidant therapy for the specified condition.
Related Concept Videos
01:30Coronary Artery Disease I: Introduction
01:26Coronary Artery Disease IV: Preventive Measures
01:27Coronary Artery Disease V: Interprofessional Care
01:30Acute Coronary Syndrome I: Introduction
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:26Angina IV: Management